Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daichi Fujimoto

Showing results (111-120 of 165) with videos related to

Pageof 17
Sort By:
Journal of Cardiovascular Computed Tomography|May 13, 2022
Diagnostic performance of fractional flow reserve derived from computed tomography in stented coronary arteriesTakayoshi Toba, Hiromasa Otake, Arjun Roy, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|January 28, 2014
Comparison of two transport systems available in Japan (TERUMO kenkiporter II and BBL Port-A-Cul) for maintenance of aerobic and anaerobic bacteriaDaichi Fujimoto, Hiroshi Takegawa, Asako Doi, et al.
Atherosclerosis|February 4, 2022
Cholesterol uptake capacity: A new measure of high-density lipoprotein functionality as a predictor of subsequent revascularization in patients undergoing percutaneous coronary interventionDaichi Fujimoto, Hiromasa Otake, Hiroyuki Kawamori, et al.
Heart and Vessels|May 31, 2022
Real-world clinical outcomes of percutaneous transluminal septal myocardial ablation for patients with drug-refractory hypertrophic obstructive cardiomyopathy: results from a retrospective multicenter registry of non-high-volume centersKoichi Nakamura, Takayoshi Toba, Hiromasa Otake, et al.
JAMA Oncology|January 7, 2021
Efficacy of Osimertinib Plus Bevacizumab vs Osimertinib in Patients With EGFR T790M-Mutated Non-Small Cell Lung Cancer Previously Treated With Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor: West Japan Oncology Group 8715L Phase 2 Randomized Clinical TrialHiroaki Akamatsu, Yukihiro Toi, Hidetoshi Hayashi, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 6, 2023
Predictors of target lesion revascularisation after drug-eluting stent implantation for calcified nodules: an optical coherence tomography studyTomoyo Hamana, Hiroyuki Kawamori, Takayoshi Toba, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 18, 2013
Cytokeratin 19 fragment predicts the efficacy of epidermal growth factor receptor-tyrosine kinase inhibitor in non-small-cell lung cancer harboring EGFR mutationKosuke Tanaka, Akito Hata, Reiko Kaji, et al.
Cancer Medicine|March 8, 2024
Mannitol versus furosemide in patients with thoracic malignancies who received cisplatin-based chemotherapy using short hydration: A randomized phase II trialEriko Murakami, Hiroaki Akamatsu, Shunsuke Teraoka, et al.
JACC. Cardiovascular Interventions|October 1, 2022
Optical Coherence Tomography Fractional Flow Reserve and Cardiovascular Outcomes in Patients With Acute Coronary SyndromeShunsuke Kakizaki, Hiromasa Otake, Fumiyasu Seike, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 31, 2022
Randomized Phase 2 Study of Osimertinib Plus Bevacizumab Versus Osimertinib for Untreated Patients With Nonsquamous NSCLC Harboring EGFR Mutations: WJOG9717L StudyHirotsugu Kenmotsu, Kazushige Wakuda, Keita Mori, et al.
Pageof 17

Showing results (111-120 of 165) with videos related to

Sort By:
Pageof 17
Journal of Cardiovascular Computed Tomography|May 13, 2022
Diagnostic performance of fractional flow reserve derived from computed tomography in stented coronary arteriesTakayoshi Toba, Hiromasa Otake, Arjun Roy, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|January 28, 2014
Comparison of two transport systems available in Japan (TERUMO kenkiporter II and BBL Port-A-Cul) for maintenance of aerobic and anaerobic bacteriaDaichi Fujimoto, Hiroshi Takegawa, Asako Doi, et al.
Atherosclerosis|February 4, 2022
Cholesterol uptake capacity: A new measure of high-density lipoprotein functionality as a predictor of subsequent revascularization in patients undergoing percutaneous coronary interventionDaichi Fujimoto, Hiromasa Otake, Hiroyuki Kawamori, et al.
Heart and Vessels|May 31, 2022
Real-world clinical outcomes of percutaneous transluminal septal myocardial ablation for patients with drug-refractory hypertrophic obstructive cardiomyopathy: results from a retrospective multicenter registry of non-high-volume centersKoichi Nakamura, Takayoshi Toba, Hiromasa Otake, et al.
JAMA Oncology|January 7, 2021
Efficacy of Osimertinib Plus Bevacizumab vs Osimertinib in Patients With EGFR T790M-Mutated Non-Small Cell Lung Cancer Previously Treated With Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor: West Japan Oncology Group 8715L Phase 2 Randomized Clinical TrialHiroaki Akamatsu, Yukihiro Toi, Hidetoshi Hayashi, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 6, 2023
Predictors of target lesion revascularisation after drug-eluting stent implantation for calcified nodules: an optical coherence tomography studyTomoyo Hamana, Hiroyuki Kawamori, Takayoshi Toba, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 18, 2013
Cytokeratin 19 fragment predicts the efficacy of epidermal growth factor receptor-tyrosine kinase inhibitor in non-small-cell lung cancer harboring EGFR mutationKosuke Tanaka, Akito Hata, Reiko Kaji, et al.
Cancer Medicine|March 8, 2024
Mannitol versus furosemide in patients with thoracic malignancies who received cisplatin-based chemotherapy using short hydration: A randomized phase II trialEriko Murakami, Hiroaki Akamatsu, Shunsuke Teraoka, et al.
JACC. Cardiovascular Interventions|October 1, 2022
Optical Coherence Tomography Fractional Flow Reserve and Cardiovascular Outcomes in Patients With Acute Coronary SyndromeShunsuke Kakizaki, Hiromasa Otake, Fumiyasu Seike, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 31, 2022
Randomized Phase 2 Study of Osimertinib Plus Bevacizumab Versus Osimertinib for Untreated Patients With Nonsquamous NSCLC Harboring EGFR Mutations: WJOG9717L StudyHirotsugu Kenmotsu, Kazushige Wakuda, Keita Mori, et al.
Pageof 17